2m 2m 2m 2m 2m 2m 2m
CORB PHRM HLDGS (CRBP)
NASDAQ
$10.44+$2.32 (+28.53%)
Price as of Sep 11, 2026 8:00 PM EDT- $157.1MMarket Cap
- -14.53%1-Year Change
- BiotechnologyIndustry
CORB PHRM HLDGS (CRBP)
$10.44+$2.32 (+28.53%)
CRBP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.12 | ||
Change | -$0.12 (-1.46%) | ||
Open | $8.38 | ||
High | $8.49 | ||
Low | $7.95 | ||
Previous Close | $8.24 | ||
Volume | 2,347,744 | ||
30-Day Average Volume | 712,310 | ||
1-Week Change | -26.71% | ||
1-Month Change | -14.62% | ||
1-Year Change | -14.53% | ||
3-Year Change | 16.17% | ||
5-Year Change | -77.25% | ||
Fundamentals | |||
Shares Outstanding | 19.3M | ||
Total Assets | $127.0M | ||
Market Cap | $157.1M | ||
Enterprise Value | $133.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$35.0M | ||
Free Cash Flow | -$29.6M | ||
EBIT | -$35.0M | ||
EBITDA | -$35.0M | ||
Net Working Capital | $101.3M | ||
EPS | -$1.81 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -4 | ||
PEG | 0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 02/14/2023 | ||
Earnings & Revenue